News

Merck extends pause on China Gardasil shipments to year end, shares slip
Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...
NJBIZ2h
Merck moves to cut $3B, jobs in latest restructuring
Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...
PharmExec1h
Merck to Reduce Costs by $3 Billion by 2027, Plans to Reinvest Savings into New Growth Areas
The restructuring includes the elimination of certain roles and a reduction in the company’s global real estate footprint.
Merck to cut jobs and costs as demand for Gardasil in China remains weak
Merck & Co on Tuesday announced job and cost cuts that it said will save $3 billion a year, after it posted lower ...
Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges
Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...
Fierce Pharma6h
Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027
Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...
Explore more
BioPharma Dive2h
Merck plans spending shift to boost business beyond Keytruda
Facing an end to Keytruda's market exclusivity, the company will cut $3 billion in costs that it plans to redeploy in support ...
Merck & Co's Earnings Outlook
Analysts estimate that Merck & Co will report an earnings per share (EPS) of $2.01. Investors in Merck & Co are eagerly ...
Leerink Partners Slashes PT on Merck & Co. (MRK) to $92 From $115
Merck & Co., Inc. (NYSE:MRK) is one of the top low volatility healthcare stocks to buy now. Analyst Daina Graybosch of ...